These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19049708)

  • 1. Brain natriuretic peptide variations are linked to volume status in hemodialysis patients.
    Roueff S; Martin E; Chauffert ML; Poli I; Kihal K; Yazbeck F; Abbassi A; Saint-Georges M
    Clin Nephrol; 2008 Dec; 70(6):508-13. PubMed ID: 19049708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in B-type natriuretic peptide levels in hemodialysis and the effect of depressed left ventricular function.
    Safley DM; Awad A; Sullivan RA; Sandberg KR; Mourad I; Boulware M; Merhi W; McCullough PA
    Adv Chronic Kidney Dis; 2005 Jan; 12(1):117-24. PubMed ID: 15719344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prohormone brain natriuretic peptide (proBNP), BNP and N-terminal-proBNP circulating levels in chronic hemodialysis patients. Correlation with ventricular function, fluid removal and effect of hemodiafiltration.
    Bargnoux AS; Klouche K; Fareh J; Barazer I; Villard-Saussine S; Dupuy AM; Leray-Moragues H; Giuliani I; Canaud B; Cristol JP
    Clin Chem Lab Med; 2008; 46(7):1019-24. PubMed ID: 18624622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of B-type natriuretic peptide to assess volume status in patients with end-stage renal disease.
    Sheen V; Bhalla V; Tulua-Tata A; Bhalla MA; Weiss D; Chiu A; Abdeen O; Mullaney S; Maisel A
    Am Heart J; 2007 Feb; 153(2):244.e1-5. PubMed ID: 17239684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain natriuretic peptide reflects individual variation in hydration status in hemodialysis patients.
    Stenberg J; Melin J; Lindberg M; Furuland H
    Hemodial Int; 2019 Jul; 23(3):402-413. PubMed ID: 30848066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of erythropoietin dose and albumin level on the plasma brain natriuretic peptide in hemodialysis patients.
    Alsuwaida A
    Saudi J Kidney Dis Transpl; 2006 Jun; 17(2):171-6. PubMed ID: 16903623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain natriuretic peptide and P wave duration in dialysis patients.
    Taskapan MC; Senel S; Ulutas O; Aksoy Y; Sahin I; Kosar F; Taskapan H
    Int Urol Nephrol; 2007; 39(2):603-8. PubMed ID: 17457688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-type natriuretic peptide is not a volume marker among patients on hemodialysis.
    Agarwal R
    Nephrol Dial Transplant; 2013 Dec; 28(12):3082-9. PubMed ID: 23525529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of brain natriuretic peptide concentrations to left ventricular function and adverse outcomes in children with end-stage renal disease undergoing hemodialysis.
    Ouali S; Bougmiza I; Abroug S; Omezzine A; Ben Salem H; Neffeti E; Remedi F; Bouslema A; Harabi A; Boughzela E
    Pediatr Cardiol; 2011 Jun; 32(5):568-77. PubMed ID: 21336977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma brain natriuretic peptide levels in chronic hemodialysis patients: influence of coronary artery disease.
    Nishikimi T; Futoo Y; Tamano K; Takahashi M; Suzuki T; Minami J; Honda T; Uetake S; Asakawa H; Kobayashi N; Horinaka S; Ishimitsu T; Matsuoka H
    Am J Kidney Dis; 2001 Jun; 37(6):1201-8. PubMed ID: 11382689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluid overload correction and cardiac history influence brain natriuretic peptide evolution in incident haemodialysis patients.
    Chazot C; Vo-Van C; Zaoui E; Vanel T; Hurot JM; Lorriaux C; Mayor B; Deleaval P; Jean G
    Nephrol Dial Transplant; 2011 Aug; 26(8):2630-4. PubMed ID: 21273234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-type natriuretic peptide is a useful biomarker for the estimation of volume overload in children with hypertension on peritoneal dialysis.
    Lee JH; Park YS
    Nephrology (Carlton); 2019 Mar; 24(3):341-346. PubMed ID: 29457863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of cardiac natriuretic peptides measured by means of competitive and non-competitive immunoassay methods in patients with renal failure on chronic hemodialysis.
    Clerico A; Caprioli R; Del Ry S; Giannessi D
    J Endocrinol Invest; 2001 Jan; 24(1):24-30. PubMed ID: 11227728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The plasma level of brain natriuretic peptide is increased in malnourished hemodialysis patients.
    Chazot C; Jean G; Vo-Van C; Collonge C; Terrat JC; Vanel T; Lorriaux C; Hurot JM; Charra B
    Blood Purif; 2009; 28(3):187-92. PubMed ID: 19648737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma concentrations of natriuretic peptides in patients on hemodialysis.
    Takahashi M; Nagake Y; Ichikawa H; Kawabata K; Nakazono H; Hirata K; Ogura T; Makino H
    Res Commun Mol Pathol Pharmacol; 1996 Apr; 92(1):19-30. PubMed ID: 8733825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in brain natriuretic peptide and atrial natriuretic peptide plasma concentrations during hemodialysis in patients with chronic renal failure.
    Haug C; Metzele A; Steffgen J; Grünert A
    Horm Metab Res; 1994 May; 26(5):246-9. PubMed ID: 8076909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of B-type natriuretic peptide to assess volume status in dialysis patients.
    Codognotto M; Piccoli A
    Am Heart J; 2007 Nov; 154(5):e31. PubMed ID: 17967574
    [No Abstract]   [Full Text] [Related]  

  • 18. Diastolic dysfunction in asymptomatic hemodialysis patients in the light of the current echocardiographic guidelines.
    Malik J; Kudlicka J; Valerianova A; Kovarova L; Kmentova T; Lachmanova J
    Int J Cardiovasc Imaging; 2019 Feb; 35(2):313-317. PubMed ID: 30815807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation, overhydration and cardiac biomarkers in haemodialysis patients: a longitudinal study.
    Jacobs LH; van de Kerkhof JJ; Mingels AM; Passos VL; Kleijnen VW; Mazairac AH; van der Sande FM; Wodzig WK; Konings CJ; Leunissen KM; van Dieijen-Visser MP; Kooman JP
    Nephrol Dial Transplant; 2010 Jan; 25(1):243-8. PubMed ID: 19692417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of hemodialysis on the body composition and cardiovascular disease markers in recently diagnosed end stage renal disease patients.
    Cakiroglu U; Akdam H; Eryilmaz U; Akgullu C; Ozbek O; Büyüköztürk AK; Akar H; Yenicerioglu Y
    Rev Assoc Med Bras (1992); 2018 Apr; 64(4):354-360. PubMed ID: 30133615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.